Our preclinical study establishes that SFN ameliorates sepsis-induced organ injury by activating the Nrf2/HO-1 pathway to suppress pyroptosis, providing a strong mechanistic rationale for clinical translation. Here, NFE2L2 is linked to Sepsis.